|
Market Closed -
Nasdaq
16:00:00 2026-09-03 EDT
|
5-day change | 1st Jan Change | ||
| 529.29 USD | -1.80% |
|
-4.36% | -21.76% |
| 08-17 | IDEXX Laboratories, Inc. - Analyst/Investor Day | |
| 08-11 | IDEXX Laboratories Launches Catalyst proBNP Test for In-Clinic Cardiac Disease Assessment | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.80% | -4.36% | -5.33% | -3.91% | -21.76% | -17.23% | +3.52% | -22.78% | +363.92% | 42.46B | |
| Average | -1.80% | -0.88% | -5.33% | -3.91% | -21.76% | -17.23% | +3.52% | -22.78% | +363.92% | 42.46B | |
| Weighted average by Cap. | -1.80% | -0.88% | -5.33% | -3.91% | -21.76% | -17.23% | +3.52% | -22.78% | +363.92% |
- Stock Market
- Stocks
- IDXX Stock
- Sector IDEXX Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
